Vincent Madison

Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor:  A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection

Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan et al. · Journal of Medicinal Chemistry · 2006 · 278 citations · Full text

Three-Dimensional Models of Wild-Type and Mutated Forms of Cytochrome P450 14α-Sterol Demethylases from <i>Aspergillus fumigatus</i> and <i>Candida albicans</i> Provide Insights into Posaconazole Binding

Xiao Li, Vincent Madison, Andrew S. Chau et al. · Antimicrobial Agents and Chemotherapy · 2004 · 266 citations · Full text

Solvent-dependent conformational distributions of some dipeptides

Vincent Madison, Kenneth D. Kopple · Journal of the American Chemical Society · 1980 · 252 citations

Engineering, Databases, Media Standards +17

Synthesis, biological activity and conformational analysis of cyclic GRF analogs

A. Felix, Edgar P. Heimer, CHING‐TSO WANG et al. · International journal of peptide & protein research · 1988 · 221 citations

Why cyclic peptides? Complementary approaches to conformations

Charles M. Deber, Vincent Madison, Elkan Blout · Accounts of Chemical Research · 1976 · 195 citations

Altmetric Attention Score, Molecular Biology, Peptide Science +19